About: Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) научна статия (bg) 2020 թվականին հրատարակված գիտական հոդված (hy) artículu científicu espublizáu en xineru de 2020 (ast) article scientifique (publié 2020) (fr) articolo scientifico (pubblicato il 2020) (it) artigo científico (publicado na 2020) (pt) artikull shkencor i botuar më 01 janar 2020 (sq) artículo científico publicado en 2020 (es) scientific article published on 01 January 2020 (en) ১ জানুয়ারি ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ (bn) im Jahr 2020 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована 1 січня 2020 (uk)
publication date	wds:Q89940438-BDB3EA07-DE3D-4E3E-ACB8-9CA00F6E03FF
publication date	2020-01-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q89940438-0FB2104C-6230-4CEB-AA0B-CEF96E74751E wds:Q89940438-402A055E-AFEF-4D9A-9094-694232F8891D wds:Q89940438-696F616A-D43A-4EC7-9FA3-888FEC842A92 wds:Q89940438-6AABCA7C-92C4-471A-8EF3-3AF80B23D69A wds:Q89940438-7677C88D-69C8-4032-960F-48DBDD4E3003 wds:Q89940438-84A00BD3-65D7-428D-AB3F-0FE547C72CFB wds:Q89940438-8908210E-C9EE-43F2-B143-7D20FE17B222 wds:Q89940438-9369D103-70CE-4DE2-BD71-C0ADE9FAE80D wds:Q89940438-9C8178A9-A07D-4FC9-97F6-0CE9489EBB2A wds:Q89940438-ABBC3C0C-BE5D-4F98-A6CA-CA74682158FB wds:Q89940438-CDD32A3F-9646-46CE-8F13-28436F16A7B4 wds:Q89940438-D586C3E0-81A4-4DA6-8C24-CCBD4EB79657 wds:Q89940438-DD27816A-9520-4E77-AF02-B2FEF7E526FC wds:Q89940438-EEEEE9E6-23CB-44A4-B278-5FA9BF840C49 wds:Q89940438-EF86C0DF-0595-488C-B561-644D7395A2AC wds:Q89940438-FA206A28-3DFE-40D3-AD57-D7B561A60F6E
cites work	Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. Value of bevacizumab in treatment of colorectal cancer: A meta-analysis Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer VEGF expression predicts survival in patients with peritoneal surface metastases from mucinous adenocarcinoma of the appendix and colon Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group. Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas Appendiceal adenocarcinoma: long-term outcomes after surgical therapy The incidence of mucinous appendiceal malignancies: a population-based study The rise in appendiceal cancer incidence: 2000-2009. NCCN Guidelines Insights: Colon Cancer, Version 2.2018 The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base Systemic chemotherapy and survival in patients with metastatic low-grade appendiceal mucinous adenocarcinoma
author name string	wds:Q89940438-572513C5-F46F-43E7-AB0C-CFC952B033D8 wds:Q89940438-8BE2B7A1-6920-4350-8807-C9DC3557D879 wds:Q89940438-BD2A478B-45FD-4F89-A735-8CE871C788BC wds:Q89940438-E539B96E-5437-4E08-A27C-4B3783BAB6AD wds:Q89940438-F97DF93B-244A-4D86-ADAA-FE6538B7B256
author name string	Jesús García Mata Carmen M Labandeira David Arias Ron Mercedes Salgado Fernández Soledad Cameselle García
rdfs:label	Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report (en) Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report (nl) Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report (sq)
skos:prefLabel	Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report (en) Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report (nl) Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report (sq)
name	Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report (en) Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report (nl) Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report (sq)
title	wds:Q89940438-12FC1C7A-FA1D-4BC1-AA91-3840C74753C6
title	Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report (en)
page(s)	wds:Q89940438-49F8B3D5-0F5B-4E0E-BA33-704637BB75FB
page(s)	69-75
instance of	wds:Q89940438-FE2BF6B9-0609-45B1-8442-562872F395A8 wds:Q89940438-cb804add-3fc4-4e8a-a055-cfa8315c7d2d
instance of	scholarly article case report
main subject	wds:Q89940438-1B393DAA-F404-4AC1-AECD-9F0A438FFCE1 wds:Q89940438-BD5BB851-0BD4-4A2F-AED7-077579B52067
main subject	bevacizumab capecitabine
PubMed ID	wds:Q89940438-B2CE11C9-5DA3-4446-82F1-0318B41117D3
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32110222
PubMed ID	32110222
published in	wds:Q89940438-4DDBD34A-E0E5-4E9B-981F-4FD5B254A89E
published in	Case reports in oncology
issue	wds:Q89940438-4CC35560-5965-4A81-BA33-73ABF7BE030C
volume	wds:Q89940438-98947AA5-0AAD-499B-A20B-0D79281674E7
issue	1
volume	13
DOI	wds:Q89940438-D9AACE2C-2523-4BD7-A567-F8D6AE4568D3
DOI	http://dx.doi.org/10.1159/000505237
DOI	10.1159/000505237
PMCID	wds:Q89940438-EFF629E1-F271-4BFC-9A8E-7E25880C9497
PMCID	7036592
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q89940438

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software